Response of extracellular matrix regulators in mouse lung after exposure to photons, protons and simulated solar particle event protons

Radiation Research

Volumn 172, Issue 1, 2009, Pages 30-41

  Tian, Jian ^a   Pecaut, Michael J ^a   Coutrakon, George B ^b   Slater, James M ^a   Gridley, Daila S ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHERN ILLINOIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B; PROTON; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; CD45 ANTIGEN; COLLAGEN; MESSENGER RNA; PTPRC PROTEIN, MOUSE; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GAMMA RADIATION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LUNG; LUNG PARENCHYMA; MOUSE; NONHUMAN; PHOTON; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WHOLE BODY RADIATION; ANIMAL; C57BL MOUSE; COSMIC RADIATION; LEUKOCYTE; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; ANTIGENS, CD45; COLLAGEN; COSMIC RADIATION; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GAMMA RAYS; LEUKOCYTES; LUNG; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; PHOTONS; PROTONS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA1;

EID: 67949118869     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1670.1     Document Type: Article

References (57)

1. K. Ohnishi and T. Ohnishi, The biological effects of space radiation during long stays in space. Biol. Sci. Space 18, 201-205 (2004).
2. J. B. West, A. R. Elliott, H. J. Guy and G. K. Prisk, Pulmonary function in space. J. Am. Med. Assoc. 277, 1957-1961 (1997).
3. C. M. Ott, T. J. Bruce and D. L. Pierson, Microbial characterization of free floating condensate aboard the Mir Space station. Microb. Ecol. 47, 133-136 (2004).
4. D. S. Gridley, M. J. Pecaut, R. Dutta-Roy and G. A. Nelson, Dose and dose rate effects of whole-body proton irradiation on leukocyte populations and lymphoid organs: Part I. Immunol. Lett. 80, 55-66 (2002).
5. D. S. Gridley and M. J. Pecaut, Whole-body irradiation and long-term modification of bone marrow-derived cell populations by low- and high-LET radiation. In Vivo 20, 781-789 (2006).
6. E. H. Kajioka, M. L. Andres, J. Li, X. W. Mao, M. F. Moyers, G. A. Nelson, J. M. Slater and D. S. Gridley, Acute effects of whole-body proton irradiation on the immune system of the mouse. Radiat. Res. 153, 587-594 (2000).
7. M. J. Pecaut, D. S. Gridley and G. A. Nelson, Long term effects of low dose whole-body proton irradiation on immunity: Shielded vs. unshielded. Aviat. Space Environ. Med. 74, 115-124 (2003).
8. D. S. Gridley, G. B. Coutrakon, A. Rizvi, E. J. M. Bayeta, X. Luo-Owen, A. Y. Makinde, F. Baqai, P. Koss, J. M. Slater and M. J. Pecaut, Low-dose photons modify liver response to simulated solar particle event protons. Radiat. Res. 169, 280-287 (2008).
9. D. S. Gridley, A. Rizvi, X. Luo-Owen, A. Y. Makinde, G. B. Coutrakon, P. Koss, J. M. Slater and M. J. Pecaut, Variable hematopoietic responses to acute photons, protons and simulated solar particle event protons. In Vivo 22, 159-170 (2008).
10. F. M. Kong, R. Ten Haken, A. Eisbruch and T. S. Lawrence, Non-small cell lung cancer therapy-related pulmonary toxicity: an update on radiation pneumonitis and fibrosis. Semin. Oncol. 32 (Suppl. 3), 42-54 (2005).
11. B. Lopez Cardozo, H. Zoetelief, D. van Bekkum, C. Zurcher and A. Hagenbeck, Lung damage following bone marrow transplantation: I. The contribution of irradiation. Int. J. Radiat. Oncol. Biol. Phys. 11, 907-914 (1985).
12. C. E. Rube, D. Uthe, K. W. Schmid, K. D. Richter, J. Wessel, A. Schuck, N. Willich and C. Rube, Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 47, 1033-1042 (2000).
13. C. M. Park, M. J. Park, H. J. Kwak, H. C. Lee, M. S. Kim, S. H. Lee, I. C. Park, C. H. Rhee and S. I. Hong, Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res. 66, 8511-8519 (2006).
14. L. W. Qian, K. Mizumoto, T. Urashima, E. Nagai, N. Maehara, N. Sato, M. Nakajima and M. Tanaka, Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin. Cancer Res. 8, 1223-1227 (2002).
15. K. Camphausen, M. A. Moses, W. D. Beecken, M. K. Khan, J. Folkman and M. S. O'Reilly, Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res. 61, 2207-2211 (2001).
16. R. Chiro, X. W. Liu and K. K. Jung, Novel functions of tissue inhibitor metalloproteinases in cell signaling. Cancer Metastasis Rev. 25, 99-113 (2006).
17. D. E. Gomez, D. F. Alonso, H. Yoshiji and U. P. Thorgeirsson, Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74, 111-122 (1997).
18. G. C. Blobe, W. P. Schiemann and H. F. Lodish, Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342, 1350-1358 (2000).
19. H. P. Rodemann and M. Bamberg, Cellular basis of radiation-induced fibrosis. Radiother. Oncol. 35, 83-90 (1995).
20. G. Murphy and A. J. Docherty, The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7, 120-125 (1992).
21. M. M. Gueders, J. M. Foidart, A. Noel and D. D. Cataldo, Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur. J. Pharmacol. 533, 133-144 (2006).
22. M. Corbel, S. Caulet-Maugendre, N. Germain, S. Molet, V. Lagente and E. Biochot, Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J. Pathol. 193, 538-545 (2001).
23. C. Ramos, M. Montaño, J. García-Alvarez, V. Ruiz, B. D. Uhal, M. Selman and A. Pardo, Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J. Respir. Cell Mol. Biol. 24, 591-598 (2001).
24. M. A. Karsdal, L. Larsen, M. T. Engsig, H. Lou, M. Ferreras, A. Lochter, J. M. Delaisse and N. T. Fored, Matrix metalloproteinase-dependent activation of latent transforming growth factor-beta controls the conversion of osteoblasts into osteocytes by blocking osteoblast apoptosis. J. Biol. Chem. 277, 44061-44067 (2002).
25. Q. Yu and I. Stamenkovic, Cell surface-localized MMP-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163-179 (2000).
26. Y. Fukuda, M. Ishizaki, S. Kudoh, M. Kitaichi and N. Yamanaka, Localization of matrix metalloproteinases-1, -2 and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Lab. Invest. 78, 687-698 (1998).
27. T. Hayashi, W. G. Stetler-Stevenson, M. V. Fleming, N. Fishback, M. N. Koss, L. A. Liotta, V. J. Ferrans and W. D. Travis, Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. Am. J. Pathol. 149, 1241-1256 (1996).
28. A. Pardo, R. Barrios, M. Gaxiola, L. Segura-Valdez, G. Carrillo, A. Estrada, M. Mejía and M. Selman, Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am. J. Respir. Crit. Care Med. 161, 1698-1704 (2000).
29. M. Selman, V. Ruiz, S. Cabrera, L. Segura, R. Ramírez, R. Barrios and A. Pardo, TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L562-L574 (2000).
30. H. Birkedal-Hansen, Role of cytokines and inflammatory mediators in tissue destruction. J. Periodontal Res. 28, 500-510 (1993).
31. C. M. Overall, J. L. Wrana and J. Sodek, Independent regulation of collagenase, 72-kDa profelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J. Biol. Chem. 264, 1860-1869 (1989).
32. J. Verstappen and J. W. Von den Hoff, Tissue inhibitors of metalloproteinases (TIMPs): Their biological functions and involvement in oral disease. J. Dent. Res. 85, 1074-1084 (2006).
33. R. Setlow, J. F. Dicello, R. J. M. Fry, J. B. Little, R. J. Preston, J. B. Smathers and R. L. Ullrich, Radiation Hazards to Crews of Interplanetary Missions: Biological Issues and Research Strategies, pp. 13-34. National Academy Press, Washington DC, 1996.
34. G. B. Coutrakon, E. R. Benton, D. S. Gridley, T. Hickey, J. Hubbard, P. Koss, M. F. Moyers, G. A. Nelson, M. J. Pecaut and K. Shahnazi, Simulation of a 36 hour solar particle event at LLUMC using a proton beam scanning system. Nucl. Instrum. Methods Phys. Res. B 261, 791-794 (2007).
35. N. Finkelstein, C.J. Johnson, R. Baggs and P. Rubin, Early alterations in extracellular matrix and transforming growth factor β gene expression in mouse lung indicative of late radiation fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 28, 621-631 (1994).
36. S. H. Kim, D. J. Lim, Y. G. Chung, T. H. Cho, S. J. Lim, W. J. Kim and J. K. Suh, Expression of TNF-α and TGF-β in the rat brain after a single high-dose irradiation. J. Korean Med. Sci. 17, 424-248 (2002).
37. K. D. Jaeger, Y. Seppenwoolde, H. H. Kampinga, L. J. Boersma, J. S. A. Belderbos and J. V. Lebesque, Significance of plasma transforming growth factor-β levels in radiotherapy for non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 58, 1378-1387 (2004).
38. A. C. Ruifrok, K. A. Mason, G. Lozano and H. D. Thames, Spatial and temporal patterns of expression of epithelial growth factor, transforming growth factor alpha and transforming growth factor beta 1-3 and their receptors in mouse jejunum after radiation treatment. Radiat. Res. 147, 1-12 (1997).
39. J. Wang, H. Zhang, C. C. Sung, K. K. Richter and M. Hauer-Jensen, Cellular sources of transforming growth-beta isoforms in early and chronic radiation enteropathy. Am. J. Pathol. 153, 1531-1540 (1998).
40. J. P. Annes, J. S. Munger and D. B. Rifkin, Making sense of latent TGFβ activation. J. Cell Sci. 116, 217-224 (2003).
41. V. Lagente, B. Manoury, S. Nenan, C. Le Quement, C. Martin-Chouly and E. Boichot, Role of matrix metalloproteinases in the development of airway inflammation and remolding. Braz. J. Med. Biol. Res. 38, 1521-1530 (2005).
42. M. Corbel, N. Theret, S. Caulet-Maugendre, N. Germain, V. Lagente, B. Clement and E. Boichot, Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity. Inflamm. Res. 50, 129-135 (2001).
43. M. K. Winkler and J. L. Fowkes, Metalloproteinase and growth factor interactions: do they play a role in pulmonary fibrosis? Am. J. Physiol. 283, 1-11 (2002).
44. J. F. Scabilloni, L. Y. Wang, J. M. Antonini, J. R. Roberts, V. Castranova and R. R. Mercer, Matrix metalloproteinase induction in fibrosis and fibrotic nodule formation due to silica inhalation. Am. J. Physiol. Lung Cell Mol. Physiol. 288, 709-717 (2005).
45. T. Ogata, T. Teshima, K. Kagawa, Y. Hishikawa, Y. Takahashi, A. Kawaguchi, Y. Suzumoto, K. Nojima, Y. Furusawa and N. Matsuura, Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res. 65, 113-120 (2005).
46. S. Cabrera, M. Gaxiola, J. L. Arreola, R. Ramírez, P. Jara, J. D'Armiento, T. Richards, M. Selman and A. Pardo, Over-expression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin. Int. J. Biochem. Cell Biol. 39, 2324-2338 (2007).
47. T. Hayakawa, K. Yamashita, K. Tanzawa, E. Uchijima and K. Iwata, Growth-promoting activity of tissue inhibitor of metal-loproteinase-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 298, 29-32 (1992).
48. T. Hayakawa, K. Yamashita, E. Ohuchi and A. Shinagawa, Cell growth-promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-2). J. Cell Sci. 107, 2373-2379 (1994).
49. Y. Jiang, I. D. Goldberg and Y. E. Shi, Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21, 2245-2252 (2002).
50. C. Strup-Perrot, M. C. Vozenin-Vrotons, M. Vandamme, C. Linard and D. Mathe, Expression of matrix metalloproteinases and tissue inhibitor metalloproteinases increases in X-irradiated rat ileum despite the disappearance of CD8a T cells. World J. Gastroenterol. 11, 6312-6321 (2005).
51. J. Araya, M. Maruyama, K. Sassa, T. Fujita, R. Hayashi, S. Matsui, T. Kashii, N. Yamashita, E. Sugiyama and M. Kobayashi, Ionizing radiation enhances matrix metal-loproteinase-2 production in human lung epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 280, 30-38 (2001).
52. R. M. Lyons, J. Keski-Oja and H. L. Moses, Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium. J. Cell Biol. 106, 1659-1665 (1988).
53. D. S. Gridley, J. R. Williams and J. M. Slater, Low-dose/low-dose-rate radiation: a feasible strategy to improve cancer radiotherapy? Cancer Ther. 3, 105-130 (2005).
54. S. B. Curtis, W. D. Hazelton, E. G. Luebeck and S. H. Moolgavkar, From mechanisms to risk estimation - bridging the chasm. Adv. Space Res. 34, 1404-1409 (2004).
55. S. A. Amundson and D. J. Chen, Inverse dose-rate effect for mutation induction by gamma-rays in human lymphoblasts. Int. J. Radiat. Biol. 69, 555-563 (1996).
56. S. J. Collis, J. M. Schwaninger, A. J. Ntambi, T. W. Keller, W. G. Nelson, L. E. Dillehay and T. L. DeWeese, Evasion of early cellular response mechanisms following low level radiation-induced DNA damage. J. Biol. Chem. 279, 49624-49632 (2004).
57. M. M. Vilenchik and A. G. Knudson, Radiation dose-rate effects, endogenous DNA damage, and signaling resonance. Proc. Natl. Acad. Sci. USA 103, 17874-17879 (2006).